NASDAQ:NRC - Nasdaq - US6373722023 - Common Stock - Currency: USD
NRC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. While NRC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NRC has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 17.91% | ||
ROE | 81.59% | ||
ROIC | 26.72% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 24.89% | ||
PM (TTM) | 17.13% | ||
GM | 60.27% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 2.1 | ||
Debt/FCF | 4.37 | ||
Altman-Z | 3.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.54 | ||
Quick Ratio | 0.54 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 16.06 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 25.23 | ||
EV/EBITDA | 10.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.96% |
16.54
-0.13 (-0.78%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 16.06 | ||
Fwd PE | N/A | ||
P/S | 2.67 | ||
P/FCF | 25.23 | ||
P/OCF | 12.89 | ||
P/B | 12.7 | ||
P/tB | N/A | ||
EV/EBITDA | 10.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 17.91% | ||
ROE | 81.59% | ||
ROCE | 36.11% | ||
ROIC | 26.72% | ||
ROICexc | 27.4% | ||
ROICexgc | 90.7% | ||
OM | 24.89% | ||
PM (TTM) | 17.13% | ||
GM | 60.27% | ||
FCFM | 10.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 2.1 | ||
Debt/FCF | 4.37 | ||
Debt/EBITDA | 1.51 | ||
Cap/Depr | 233.71% | ||
Cap/Sales | 10.12% | ||
Interest Coverage | 13.06 | ||
Cash Conversion | 70.8% | ||
Profit Quality | 61.7% | ||
Current Ratio | 0.54 | ||
Quick Ratio | 0.54 | ||
Altman-Z | 3.75 |